FR3075619B1 - Derives xylosides de resveratrol pour leur utilisation en cosmetique - Google Patents

Derives xylosides de resveratrol pour leur utilisation en cosmetique Download PDF

Info

Publication number
FR3075619B1
FR3075619B1 FR1762844A FR1762844A FR3075619B1 FR 3075619 B1 FR3075619 B1 FR 3075619B1 FR 1762844 A FR1762844 A FR 1762844A FR 1762844 A FR1762844 A FR 1762844A FR 3075619 B1 FR3075619 B1 FR 3075619B1
Authority
FR
France
Prior art keywords
resveratrol
cosmetics
formula
xyloside
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1762844A
Other languages
English (en)
Other versions
FR3075619A1 (fr
Inventor
Xavier Marat
Maria Dalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1762844A priority Critical patent/FR3075619B1/fr
Priority to EP18826669.6A priority patent/EP3727301A1/fr
Priority to PCT/EP2018/086219 priority patent/WO2019122140A1/fr
Priority to US16/955,616 priority patent/US11654096B2/en
Priority to JP2020533854A priority patent/JP2021507905A/ja
Priority to CN201880082655.4A priority patent/CN111491605A/zh
Publication of FR3075619A1 publication Critical patent/FR3075619A1/fr
Application granted granted Critical
Publication of FR3075619B1 publication Critical patent/FR3075619B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne l'utilisation d'un composé de formule (I) : dans laquelle R1, R2 et R3 désignent indépendamment : - un groupe de formule (II), ou - un atome d'hydrogène H, étant entendu qu'au moins un des radicaux R1, R2, R3 désigne un groupe de formule (II) ; ainsi que leurs sels, leurs solvates, et/ou leurs isomères, pour prévenir et/ou traiter cosmétiquement les signes cutanés du vieillissement.
FR1762844A 2017-12-21 2017-12-21 Derives xylosides de resveratrol pour leur utilisation en cosmetique Active FR3075619B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR1762844A FR3075619B1 (fr) 2017-12-21 2017-12-21 Derives xylosides de resveratrol pour leur utilisation en cosmetique
EP18826669.6A EP3727301A1 (fr) 2017-12-21 2018-12-20 Dérivés xylosides de resvératrol pour leur utilisation en cosmétique
PCT/EP2018/086219 WO2019122140A1 (fr) 2017-12-21 2018-12-20 Dérivés xylosides de resvératrol pour leur utilisation en cosmétique
US16/955,616 US11654096B2 (en) 2017-12-21 2018-12-20 Xyloside derivatives of resveratrol for use thereof in cosmetics
JP2020533854A JP2021507905A (ja) 2017-12-21 2018-12-20 化粧品に使用するためのレスベラトロールのキシロシド誘導体
CN201880082655.4A CN111491605A (zh) 2017-12-21 2018-12-20 用于化妆品的白藜芦醇的木糖苷衍生物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1762844A FR3075619B1 (fr) 2017-12-21 2017-12-21 Derives xylosides de resveratrol pour leur utilisation en cosmetique
FR1762844 2017-12-21

Publications (2)

Publication Number Publication Date
FR3075619A1 FR3075619A1 (fr) 2019-06-28
FR3075619B1 true FR3075619B1 (fr) 2020-05-22

Family

ID=62067627

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1762844A Active FR3075619B1 (fr) 2017-12-21 2017-12-21 Derives xylosides de resveratrol pour leur utilisation en cosmetique

Country Status (6)

Country Link
US (1) US11654096B2 (fr)
EP (1) EP3727301A1 (fr)
JP (1) JP2021507905A (fr)
CN (1) CN111491605A (fr)
FR (1) FR3075619B1 (fr)
WO (1) WO2019122140A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3097435A1 (fr) * 2019-06-19 2020-12-25 L'oreal Dérivés xylosides de resvératrol pour leur utilisation en cosmétique
FR3100981A1 (fr) * 2019-06-19 2021-03-26 L'oreal Dérivés xylosides de resvératrol pour leur utilisation en cosmétique
CN118146283A (zh) * 2024-05-09 2024-06-07 四川省农业科学院农产品加工研究所(四川省农业科学院食物与营养健康研究所) 白藜芦醇-葡萄糖偶联物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270780B1 (en) * 1997-07-25 2001-08-07 Chesebrough-Pond's Usa Co., Division Of Conopco Cosmetic compositions containing resveratrol
FR2770776B1 (fr) * 1997-11-07 2000-03-17 Lvmh Rech Utilisations du d-xylose et de ses esters pour ameliorer la fonctionnalite des cellules de l'epiderme
FR2812195B1 (fr) * 2000-07-28 2003-07-11 Oreal Compositions a application topique comprenant des hydroxystilbenes glucosyles et utilations
WO2010046926A2 (fr) 2008-10-17 2010-04-29 Aptuit Laurus Pvt Ltd Nouveaux analogues de stilbene novel stilbene analogs
FR2939797B1 (fr) * 2008-12-12 2011-01-21 Oreal Nouveaux composes c-xylosides aryle et utilisation en cosmetique
JP2012240956A (ja) * 2011-05-19 2012-12-10 Kakei Gakuen レスベラトロールを含む剤、及び組成物
ES2879955T3 (es) * 2014-04-09 2021-11-23 Ezaki Glico Co Inhibidor del envejecimiento de la piel y concentrado de resveratrol 3-O-alfa-glucósido
FR3029911B1 (fr) * 2014-12-12 2018-03-09 L'oreal Nouveaux composes 1,2-diphenylethylene glycol pour lutter contre le vieillissement cutane et utilisation en cosmetique

Also Published As

Publication number Publication date
WO2019122140A1 (fr) 2019-06-27
EP3727301A1 (fr) 2020-10-28
CN111491605A (zh) 2020-08-04
FR3075619A1 (fr) 2019-06-28
JP2021507905A (ja) 2021-02-25
US11654096B2 (en) 2023-05-23
US20210052479A1 (en) 2021-02-25

Similar Documents

Publication Publication Date Title
MA52486B1 (fr) Pyridazinones utilisés en tant qu'inhibiteurs de parp7
MD3551622T2 (ro) Modulator al regulatorului conductanței transmembranare în fibroză chistică, compoziții farmaceutice, metode de tratament și procedeu pentru fabricarea modulatorului
MA42109A (fr) Amides hétérocycliques utilisés en tant qu'inhibiteurs de kinase
FR3075619B1 (fr) Derives xylosides de resveratrol pour leur utilisation en cosmetique
MX2009007075A (es) Metodos de uso para analogos de ciclopamina.
MA42410A (fr) Oxystérols et leurs méthodes d'utilisation
MA43169B1 (fr) Composés héterocycliques en tant qu' inhibiteurs pi3k-gamma
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
HRP20050533A2 (en) Aminoindazole derivatives and use thereof as kinase inhibitors
MA30911B1 (fr) Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine
MA45598B1 (fr) Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda
MA43409B1 (fr) Composés polycycliques à utiliser en tant qu'inhibiteurs de la tyrosine kinase de bruton
MA29160B1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
MA30912B1 (fr) Nouveaux derives de phenylsulfamoyl-benzamide en tant qu'antagonistes de la bradykinine
CY1107274T1 (el) Παραγωγα αλφα-αμινοαμιδιου χρησιμα σαν παραγοντες κατα της ημικρανιας
MA39170A1 (fr) Composes inhibiteurs de sérine/thréonine kinase pour leurs utilisations dans le traitement du cancer
MA47736B1 (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
MA34968B1 (fr) Urées asymétriques et utilisations médicales de celles-ci
MA39315A1 (fr) Dérivés de pyridazine à utiliser dans la prévention ou le traitement d'un trouble ataxique
MA38410B1 (fr) Composés d'azétidinyloxyphénylpyrrolidine
MA43913B1 (fr) Modulateurs allostériques positifs du récepteur m1 muscarinique
MX2020012281A (es) Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas.
MA39253A1 (fr) Composés hétéroaryle bicycliques substitués utilisés comme agonistes de rxr
IN2015DN02337A (fr)
FR3051672B1 (fr) Composition cosmetique ou dermocosmetique comprenant un extrait de sureau et un derive organique de silicium

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20190628

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7